Friedrich Förster

19PUBLICATIONS
70CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.

|Dec 12, 2025
Performance of major liver resection for gallbladder cancer-a western retrospective single center cohort study.

Constantin Scholz, Maria Hoppe-Lotichius, Arndt Weinmann

|Feb 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC.

Eva Stockinger, Hendrik Luxenburger, Dominik Bettinger

|Sep 27, 2023
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.

Natascha Roehlen, Fabian Stoehr, Lukas Müller

|Nov 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case report.

Simon Johannes Gairing, Eva Maria Schleicher, Lukas Müller

|Mar 15, 2022
pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages.

Leonard Kaps, Anne Huppertsberg, Niklas Choteschovsky

Pageof 4

Frequent Collaborators

7 joint publications

Simon Johannes Gairing

6 joint publications

Roman Kloeckner

5 joint publications

Fabian Bartsch

4 joint publications

Arndt Weinmann